LifeVantage Co. (NASDAQ:LFVN - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.82 and traded as high as $12.76. LifeVantage shares last traded at $12.30, with a volume of 91,453 shares changing hands.
The company's fifty day moving average price is $9.74 and its 200 day moving average price is $7.82. The company has a market capitalization of $156.22 million, a P/E ratio of 43.93 and a beta of 0.84.
LifeVantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a return on equity of 27.85% and a net margin of 1.47%. The firm had revenue of $48.93 million for the quarter.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 1.30%. The ex-dividend date of this dividend was Monday, September 9th. LifeVantage's payout ratio is currently 57.14%.
Several large investors have recently modified their holdings of the business. Hillsdale Investment Management Inc. bought a new stake in LifeVantage in the first quarter valued at $76,000. Hantz Financial Services Inc. bought a new stake in LifeVantage in the second quarter valued at $91,000. Ritholtz Wealth Management increased its stake in LifeVantage by 62.0% in the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company's stock valued at $346,000 after purchasing an additional 10,974 shares in the last quarter. Empowered Funds LLC increased its stake in LifeVantage by 8.1% in the first quarter. Empowered Funds LLC now owns 76,203 shares of the company's stock valued at $461,000 after purchasing an additional 5,742 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company's stock valued at $1,378,000 after purchasing an additional 6,121 shares in the last quarter. Institutional investors own 35.32% of the company's stock.
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider LifeVantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.
While LifeVantage currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.